prostate cancer diagnosis UAE

prostate cancer diagnosis UAE Early prostate cancer diagnosis in the UAE starts with a simple PSA blood test, and most men should discuss screening from age 50, or 45 if they are at higher risk. Caught early, prostate cancer is one of the most treatable cancers in men, yet many cases in the Emirates are still found late because the disease rarely causes symptoms at first. This guide explains how screening works in Dubai and across the UAE, which tests doctors use, what they cost in AED, how health insurance applies, and when to book an appointment with an expert urologist. The goal is simple: help you make an informed decision about your own health. What Is Prostate Cancer (PCa)? Prostate cancer, often shortened to PCa in medical literature, begins when cells in the prostate gland grow out of control. The prostate is a small, walnut-sized gland below the bladder that produces part of the seminal fluid. It naturally enlarges with age, which is why age is the strongest single risk factor. After skin cancer, prostate cancer is among the most common cancers in men worldwide. In the UAE, doctors describe it as one of the most common cancers in Emirati men over 50, and Abu Dhabi registry data has ranked it among the top three cancers nationally (Khaleej Times, Gulf News). Prostate Cancer vs. an Enlarged Prostate: Key Differences An enlarged prostate (BPH) and prostate cancer can cause similar urinary symptoms, so it is important to learn the differences: Feature Enlarged Prostate (BPH) Prostate Cancer (PCa) Nature Benign, non-cancerous growth Malignant tumour that can spread Early symptoms Weak flow, frequent urination at night Usually none in early stages PSA level Can be mildly raised Can be raised, sometimes rising quickly Spread Does not spread to other parts of the body Advanced cases can spread to bones and lymph nodes Because early PCa is usually silent, waiting for symptoms is not a safe strategy. Screening is what finds it early. Prostate Cancer Screening Guidelines in the UAE by Age UAE specialists generally advise men to start the screening conversation at 50, or at 45 with risk factors, and to repeat a normal PSA test every one to two years (Khaleej Times). Current European guidelines also favour risk-based PSA testing, with an MRI before any biopsy (Gulf News). Age / Risk Group Typical Recommendation 40–44, very high risk (BRCA1/2 carrier, strong family history) Discuss early testing with a urologist 45–49, higher risk (father or brother with PCa, African ancestry) Start PSA screening 50–69, average risk Discuss PSA screening; repeat every 1–2 years if normal 70+ Individual decision based on general health and life expectancy These are general guidelines, not personal medical advice. Your doctor will tailor the plan to your history. Who Is at Higher Risk? Men over 50; most diagnoses happen between 65 and 69. A father, brother or son diagnosed with prostate cancer. Inherited BRCA1 or BRCA2 gene changes. Men of African ancestry. Doctors also warn that late-stage diagnosis is more frequent in the UAE than in many countries, partly because men delay screening (Arabian Business). Tests Used for Prostate Cancer Diagnosis in Dubai and the UAE Diagnosis follows a step-by-step pathway, and each step decides whether the next one is needed. Most men stop after step 1 with a normal result. PSA Blood Test: Measures prostate-specific antigen, a protein made by the prostate gland. A raised PSA does not mean cancer; infection or an enlarged prostate can also raise it. Digital Rectal Exam (DRE): A quick physical check by a urologist for lumps or hard areas. Multiparametric MRI: Shows suspicious areas and helps avoid unnecessary biopsies. Many Dubai hospitals now offer MRI before biopsy. Targeted Biopsy: Small tissue samples confirm whether cancer is present and give a Gleason score (grade). Molecular and Genomic Tests: Advanced tests on blood, urine or biopsy tissue estimate how aggressive the cancer is, helping men choose between active surveillance and treatment. Staging Scans: For confirmed or advanced cases, PSMA PET-CT or a bone scan checks whether cancer has spread. After diagnosis, ask your doctor three questions: What type, what grade, and what stage is my cancer? Cost of Prostate Cancer Screening in Dubai (AED) and Insurance A basic PSA screening with a consultation in Dubai typically costs around AED 250–300, and many hospitals run lower-priced offers during Movember. Published package prices from one Dubai hospital group give a useful benchmark: Service Listed Price (AED) PSA test + consultation (source) 300 (250 in November) Comprehensive prostate screening: PSA, ultrasound, urine flow test (source ) 1,200 Initial urologist consultation in Dubai (source) 240–750 Prices change often, so confirm the current fee when you book. Does Health Insurance Cover Prostate Cancer Screening in the UAE? Coverage depends on your policy. Dubai’s mandatory basic plan covers screening and treatment for breast, colorectal and cervical cancer under the DHA Basmah initiative, but prostate cancer is not one of the three named cancers (DHA). The UAE Insurance Authority has said screening cover always depends on the policy’s contract terms (Gulf News). In practice, a PSA test ordered for symptoms is often covered, while routine screening may need an enhanced plan. Check with your insurer before your visit. Travelling to the UAE for Prostate Care The UAE is a regional hub for medical travel, with internationally accredited hospitals in Dubai and Abu Dhabi. If you travel for diagnosis or treatment, bring previous PSA results, scans and biopsy reports, and confirm whether your travel or international health insurance covers care abroad. Prostate Cancer Treatment and Care in UAE Hospitals Treatment depends on the cancer’s grade, stage, your age and overall health. When diagnosed early, five-year survival reaches 98–99% (Fakeeh University Hospital). Treatment Option Best Suited For Active surveillance Low-risk, slow-growing cancer; regular PSA, MRI and biopsy checks Robotic radical prostatectomy Localised cancer in fit men; removes the whole gland Radiotherapy (external or brachytherapy) Localised or locally advanced cancer Focal therapy (HIFU, cryotherapy) Small, well-defined tumours in selected patients Hormone therapy